drugset / Trial / NCT00996151

Testosterone MD-Lotion Residual Washing Study

NCT00996151

Phase 1 Completed 10 enrolled Acrux DDS Pty Ltd
NaSingle-groupOpen-label

Summary

The study will evaluate the amount of Testosteron MD-Lotion 2% remaining on the axilla after a single dose application in healthy males who undergo a post dose washing procedure.

Timeline

Start
2009-12
Primary completion
2010-02
Completion
2010-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Testosterone Small molecule 2 % Topical

Indications